Latest & greatest articles for asthma

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on asthma or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on asthma and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for asthma

1. A Focused Update on the Management of Very Mild and Mild Asthma

A Focused Update on the Management of Very Mild and Mild Asthma Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=ucts20 Canadian Journal of Respiratory, Critical Care, and Sleep Medicine Revue canadienne des soins respiratoires et critiques et de la médecine du sommeil ISSN: (Print) (Online) Journal homepage: https://www.tandfonline.com/loi/ucts20 2021 Canadian Thoracic Society Guideline – A focused update (...) on the management of very mild and mild asthma Connie L. Yang, Elizabeth Anne Hicks, Patrick Mitchell, Joe Reisman, Delanya Podgers, Kathleen M. Hayward, Mark Waite & Clare D. Ramsey To cite this article: Connie L. Yang, Elizabeth Anne Hicks, Patrick Mitchell, Joe Reisman, Delanya Podgers, Kathleen M. Hayward, Mark Waite & Clare D. Ramsey (2021): 2021 Canadian Thoracic Society Guideline – A focused update on the management of very mild and mild asthma, Canadian Journal of Respiratory, Critical Care, and Sleep

2021 Canadian Thoracic Society

2. Beclometasone dipropionate/formoterol fumarate dehydrate/glycopyrronium bromide (Trimbow) - asthma

Beclometasone dipropionate/formoterol fumarate dehydrate/glycopyrronium bromide (Trimbow) - asthma Published 8 March 2021 1 Product update SMC2335 beclometasone dipropionate / formoterol fumarate dihydrate / glycopyrronium 87mcg / 5mcg / 9mcg (Trimbow®) Chiesi Limited 5 February 2021 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product and, following review by the SMC executive, advises NHS Boards and Area Drug and Therapeutics Committees (ADTCs) on its use (...) in NHSScotland. The advice is summarised as follows: ADVICE: following an abbreviated submission beclometasone dipropionate, formoterol fumarate dihydrate, glycopyrronium (Trimbow®) is accepted for use within NHSScotland. Indication under review: maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year. Beclometasone

2021 Scottish Medicines Consortium

3. Sensor-Based Electronic Monitoring for Asthma: A Randomized Controlled Trial

Sensor-Based Electronic Monitoring for Asthma: A Randomized Controlled Trial Sensor-Based Electronic Monitoring for Asthma: A Randomized Controlled Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. National Institutes of Health National Library of Medicine National Center (...) Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Pediatrics Actions . 2021 Jan;147(1):e20201330. doi: 10.1542/peds.2020-1330. Sensor-Based Electronic Monitoring for Asthma: A Randomized Controlled Trial , , , , , , , Affiliations Expand Affiliations 1 Center for Food Allergy and Asthma Research and Institute for Public Health and Medicine, Feinberg School of Medicine, Northwestern University

2021 EvidenceUpdates

4. Bronchial Thermoplasty Induced Airway Smooth Muscle Reduction and Clinical Response in Severe Asthma. The TASMA Randomized Trial

Bronchial Thermoplasty Induced Airway Smooth Muscle Reduction and Clinical Response in Severe Asthma. The TASMA Randomized Trial Bronchial Thermoplasty Induced Airway Smooth Muscle Reduction and Clinical Response in Severe Asthma. The TASMA Randomized Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging (...) : Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Randomized Controlled Trial Am J Respir Crit Care Med Actions . 2021 Jan 15;203(2):175-184. doi: 10.1164/rccm.201911-2298OC. Bronchial Thermoplasty Induced Airway Smooth Muscle Reduction and Clinical Response in Severe Asthma. The TASMA

2021 EvidenceUpdates

5. Beclometasone with formoterol (Fostair) for asthma

Beclometasone with formoterol (Fostair) for asthma Beclometasone with formoterol (Fostair) for asthma - NPS MedicineWise Log In Menu During the COVID-19 pandemic, you need to continue to take your usual medicines and stay as healthy as possible. Health professionals also need to stay up to date with the latest evidence as it emerges. Our information hub has important information for everyone. Featured topics 17 Feb 2021 22 Feb 2021 24 Dec 2020 22 Dec 2020 Featured article Find out more about (...) in Beclometasone with formoterol (Fostair) for asthma Another ICS + LABA FDC for maintenance treatment of asthma in adults 8 minutes 7 December 2020 Key points Beclometasone + formoterol (eformoterol) FDC is now PBS-listed for maintenance treatment of asthma in adults It is not PBS-listed for maintenance and reliever therapy or as an anti-inflammatory reliever. The addition of another ICS + LABA FDC to the PBS provides more treatment choices for patients and prescribers. Beclometasone + formoterol FDC

2021 National Prescribing Service Limited (Australia)

6. 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group Full Text available with Trip Pro

2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History (...) at most: Send even when there aren't any new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation J Allergy Clin Immunol Actions . 2020 Dec;146(6):1217-1270. doi: 10.1016/j.jaci.2020.10.003. 2020 Focused Updates to the Asthma Management Guidelines: A Report

2021 EvidenceUpdates

7. Mepolizumab for treating severe eosinophilic asthma

Mepolizumab for treating severe eosinophilic asthma Mepolizumab for treating severe eosinophilic asthma T echnology appraisal guidance Published: 3 February 2021 www.nice.org.uk/guidance/ta671 © NICE 2021. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Your responsibility Your responsibility The recommendations in this guidance represent the view of NICE, arrived at after careful consideration of the evidence available. When (...) sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Mepolizumab for treating severe eosinophilic asthma (TA671) © NICE 2021. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 14Contents Contents 1 Recommendations 4 Why the committee made these recommendations 5 2 Information about mepolizumab 6 Marketing authorisation indication 6 Dosage

2021 National Institute for Health and Clinical Excellence - Technology Appraisals

8. Group-randomized trial of tailored brief shared decision-making to improve asthma control in urban black adults

Group-randomized trial of tailored brief shared decision-making to improve asthma control in urban black adults Group-randomized trial of tailored brief shared decision-making to improve asthma control in urban black adults - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get (...) brief shared decision-making to improve asthma control in urban black adults , , , , , , , , , , Affiliations Expand Affiliations 1 Columbia University School of Nursing, New York, NY, USA. 2 University of Pennsylvania School of Nursing, Philadelphia, PA, USA. 3 Department of Emergency Medicine, Yale University School of Medicine, New Haven, CT, USA. 4 Columbia University School of Nursing, Columbia University Mailman School of Public Health, New York, NY, USA. 5 Center for Health Behavior Research

2021 EvidenceUpdates

9. Nasal High Flow Oxygen Versus Conventional Oxygen Therapy for Acute Severe Asthma Patients: A Pilot Randomized Controlled Trial Full Text available with Trip Pro

Nasal High Flow Oxygen Versus Conventional Oxygen Therapy for Acute Severe Asthma Patients: A Pilot Randomized Controlled Trial Nasal High-flow Oxygen Versus Conventional Oxygen Therapy for Acute Severe Asthma Patients: A Pilot Randomized Controlled Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging (...) of print. Nasal High-flow Oxygen Versus Conventional Oxygen Therapy for Acute Severe Asthma Patients: A Pilot Randomized Controlled Trial , , , , Affiliations Expand Affiliation 1 From the Department of Emergency Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand. PMID: 33258213 DOI: Item in Clipboard Nasal High-flow Oxygen Versus Conventional Oxygen Therapy for Acute Severe Asthma Patients: A Pilot Randomized Controlled Trial Onlak Ruangsomboon et al. Acad Emerg Med

2021 EvidenceUpdates

10. Do Inhaled Corticosteroids Decrease Hospital Admissions among Patients With Moderate to Severe Asthma Attacks?

Do Inhaled Corticosteroids Decrease Hospital Admissions among Patients With Moderate to Severe Asthma Attacks? Does b-Blockade for Treatment of Refractory Ventricular Fibrillation or Pulseless Ventricular Tachycardia Improve Outcomes? TAKE-HOME MESSAGE b-Blockade may be associated with improved rates of return of spontaneous circulation and survival with favorable neurologic outcome in patients with refractory ventricular ?brillation or pulseless ventricular tachycardia. EBEM Commentators Drew

2020 Annals of Emergency Medicine Systematic Review Snapshots

11. Effect of vitamin D supplementation on asthma control in patients with vitamin D deficiency: the ACVID randomised clinical trial

Pulmonology, Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar, Murcia, Spain. PMID: 33154023 DOI: Item in Clipboard Full-text links Cite Display options Display options Format Abstract Background: The relationship between asthma and vitamin D deficiency has been known for some time. However, interventional studies conducted in this regard have shown conflicting results. Objective: To evaluate the efficacy of vitamin D supplementation in asthmatic patients in improving the degree of control (...) of asthma. Methods: Randomised, triple-blind, placebo-controlled, parallel-group study in adult asthmatic patients with serum 25-hydroxyvitamin-D 3 <30 ng/mL. The intervention group received oral supplementation with 16 000 IU of calcifediol per week, and the control group had placebo added to their usual asthma treatment. The study period was 6 months. The primary endpoint was the degree of asthma control as determined by the asthma control test (ACT). Secondary endpoints included quality of life

2020 EvidenceUpdates

12. Indacaterol acetate/mometasone furoate (Atectura Breezhaler) for the maintenance treatment for asthma in adults and adolescents of 12 years and older

Indacaterol acetate/mometasone furoate (Atectura Breezhaler) for the maintenance treatment for asthma in adults and adolescents of 12 years and older Indacaterol acetate/mometasone furoate (Atectura® Breezhaler®) for the maintenance treatment for asthma in adults and adolescents of 12 years and older | Report | National Health Care Institute You are here: Indacaterol acetate/mometasone furoate (Atectura® Breezhaler®) for the maintenance treatment for asthma in adults and adolescents of 12 years (...) and older Search within English part of National Health Care Institute Search Indacaterol acetate/mometasone furoate (Atectura® Breezhaler®) for the maintenance treatment for asthma in adults and adolescents of 12 years and older Zorginstituut Nederland has completed its assessment whether indacaterol acetate/mometasone furoate (Atectura® Breezhaler®) can be included in the Medication Reimbursement System (GVS). The Zorginstituut's advice is to include Atectura® Breezhaler® in List 1B of the GVS

2020 National Health Care Institute (Zorginstituut Nederland)

13. Indacaterol/glycopyrronium/mometasone (Enerzair Breezhaler) for maintenance treatment of asthma in adult patients

Indacaterol/glycopyrronium/mometasone (Enerzair Breezhaler) for maintenance treatment of asthma in adult patients Indacaterol/glycopyrronium/mometasone (Enerzair® Breezhaler®) for maintenance treatment of asthma in adult patients | Report | National Health Care Institute You are here: Indacaterol/glycopyrronium/mometasone (Enerzair® Breezhaler®) for maintenance treatment of asthma in adult patients Search within English part of National Health Care Institute Search Indacaterol/glycopyrronium (...) /mometasone (Enerzair® Breezhaler®) for maintenance treatment of asthma in adult patients Zorginstituut Nederland has completed its assessment whether indacaterol/glycopyrronium/mometasone (Enerzair® Breezhaler®) for maintenance treatment of asthma in adult patients can be included in the Medication Reimbursement System (GVS). The Zorginstituut's advice is to include Enerzair® Breezhaler® in List 1B of the GVS on technical grounds. Active ingredients of Enerzair® Breezhaler® already included in the GVS

2020 National Health Care Institute (Zorginstituut Nederland)

14. Self-titration of inhaled corticosteroid and beta2-agonist in response to symptoms in mild asthma: a pre-specified analysis from the PRACTICAL randomised controlled trial

Self-titration of inhaled corticosteroid and beta2-agonist in response to symptoms in mild asthma: a pre-specified analysis from the PRACTICAL randomised controlled trial Self-titration of inhaled corticosteroid and β 2-agonist in response to symptoms in mild asthma: a pre-specified analysis from the PRACTICAL randomised controlled trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History (...) navigation Eur Respir J Actions . 2020 Oct 8;56(4):2000170. doi: 10.1183/13993003.00170-2020. Print 2020 Oct. Self-titration of inhaled corticosteroid and β 2 -agonist in response to symptoms in mild asthma: a pre-specified analysis from the PRACTICAL randomised controlled trial , , , , , , , , , , Affiliations Expand Affiliations 1 Medical Research Institute of New Zealand, Wellington, New Zealand. 2 School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand. 3 Dept

2020 EvidenceUpdates

15. Asthma in adults and adolescents: what’s new for mild asthma management?

Asthma in adults and adolescents: what’s new for mild asthma management? Asthma in adults and adolescents: what’s new for mild asthma management? - NPS MedicineWise Log In Menu During the COVID-19 pandemic, you need to continue to take your usual medicines and stay as healthy as possible. Health professionals also need to stay up to date with the latest evidence as it emerges. Our information hub has important information for everyone. Featured topics 02 Sep 2020 06 Aug 2020 03 Aug 2020 24 Jun (...) in Log in All fields are required Email address* Password* Log in Rate us How likely is it that you would recommend our site to a friend? Please help us to improve our services by answering the following question How likely is it that you would recommend our site to a friend? 0 1 2 3 4 5 6 7 8 9 10 0 = Not likely at all 10 = Extremely likely Please feel free to tell us why SUBMIT Asthma in adults and adolescents: what’s new for mild asthma management? A new approach offers an alternative to low-dose

2020 National Prescribing Service Limited (Australia)

16. Effectiveness of a Home- and School-Based Asthma Educational Program for Head Start Children With Asthma: A Randomized Clinical Trial

Effectiveness of a Home- and School-Based Asthma Educational Program for Head Start Children With Asthma: A Randomized Clinical Trial Effectiveness of a Home- and School-Based Asthma Educational Program for Head Start Children With Asthma: A Randomized Clinical Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 (...) /jamapediatrics.2020.3375. Online ahead of print. Effectiveness of a Home- and School-Based Asthma Educational Program for Head Start Children With Asthma: A Randomized Clinical Trial , , , , , , Affiliations Expand Affiliations 1 Division of Pulmonary and Critical Care Medicine, The Johns Hopkins University, Baltimore, Maryland. 2 Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston. PMID: 33016987 PMCID: PMC7536623 (available on 2021-10-05 ) DOI: Item in Clipboard

2020 EvidenceUpdates

17. Effect of Avoiding Cow's Milk Formula at Birth on Prevention of Asthma or Recurrent Wheeze Among Young Children: Extended Follow-up From the ABC Randomized Clinical Trial Full Text available with Trip Pro

Effect of Avoiding Cow's Milk Formula at Birth on Prevention of Asthma or Recurrent Wheeze Among Young Children: Extended Follow-up From the ABC Randomized Clinical Trial Effect of Avoiding Cow's Milk Formula at Birth on Prevention of Asthma or Recurrent Wheeze Among Young Children: Extended Follow-up From the ABC Randomized Clinical Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History (...) navigation JAMA Netw Open Actions . 2020 Oct 1;3(10):e2018534. doi: 10.1001/jamanetworkopen.2020.18534. Effect of Avoiding Cow's Milk Formula at Birth on Prevention of Asthma or Recurrent Wheeze Among Young Children: Extended Follow-up From the ABC Randomized Clinical Trial , , , , , , , Affiliations Expand Affiliations 1 Division of Molecular Epidemiology, Jikei University School of Medicine, Tokyo, Japan. 2 Department of Pediatrics, Jikei University School of Medicine, Tokyo, Japan. PMID: 33006618

2020 EvidenceUpdates

18. The association between COVID-19 and asthma: a systematic review and meta-analysis Full Text available with Trip Pro

The association between COVID-19 and asthma: a systematic review and meta-analysis The association between COVID‐19 and asthma: A systematic review and meta‐analysis - Wang - 2020 - Clinical & Experimental Allergy - Wiley Online Library Working off-campus? Learn about our By continuing to browse this site, you agree to its use of cookies as described in our . Search within Search term Search term RESEARCH LETTER Free Access The association between COVID‐19 and asthma: A systematic review (...) September 2020 Citations: Yushu Wang and Guangyu Ao contributed equally to this work. Give access Share full-text access Please review our and check box below to share full-text version of article. I have read and accept the Wiley Online Library Terms and Conditions of Use Shareable Link Use the link below to share a full-text version of this article with your friends and colleagues. Copy URL Share a link Share on However, there is no clear evidence about whether patients with asthma were at a higher

2020 Clinical & Experimental Allergy

19. Primary prevention of asthma: from risk and protective factors to targeted strategies for prevention. Full Text available with Trip Pro

Primary prevention of asthma: from risk and protective factors to targeted strategies for prevention. Asthma is a complex disease that often starts in childhood. Genomic and environmental factors as well as aberrant immune maturation early in life can contribute to the onset of disease, with great disparity over time and geographical regions. Epidemiological studies have scrutinised environmental exposures and attempted to translate these exposures into prevention strategies. Some approaches (...) for patients with asthma have been successful (eg, smoking ban, the Finnish Asthma Programme), and primary prevention of wheeze in pre-school children (age 0-5 years) by the supplementation of vitamin D or fish oil, or both, to pregnant women seems promising. Several recent prevention initiatives are based on strong asthma-protective environmental microbial exposures associated with traditional rural lifestyles. Preclinical studies with various bacterial lysates, bacterial and dietary metabolites

2020 Lancet

20. Sublingual immunotherapy for asthma. (Abstract)

Sublingual immunotherapy for asthma. Asthma is a common long-term respiratory disease affecting approximately 300 million people worldwide. Approximately half of people with asthma have an important allergic component to their disease, which may provide an opportunity for targeted treatment. Sublingual immunotherapy (SLIT) aims to reduce asthma symptoms by delivering increasing doses of an allergen (e.g. house dust mite, pollen extract) under the tongue to induce immune tolerance. Fifty-two (...) articles found trials up to 25 March 2015. The most recent search for trials for the current update was conducted on 29 October 2019.We included parallel randomised controlled trials, irrespective of blinding or duration, that evaluated sublingual immunotherapy versus placebo or as an add-on to standard asthma management. We included both adults and children with asthma of any severity and with any allergen-sensitisation pattern. We included studies that recruited participants with asthma, rhinitis

2020 Cochrane